Abstract
Qingfei Paidu (QFPD) granules have played a critical role during the Coronavirus Disease 2019 (COVID-19) in China. However, worldwide acceptance has been a problem because of the complex ingredients and unique theory of treatment. In this study, high-performance liquid chromatography (HPLC)-Q Exactive Orbitrap-mass spectrometry (MS) and the Orbitrap traditional Chinese medicine library (OTCML) were used to investigate the chemical constituents of QFPD granules. By comparing retention times, masses, isotope ion patterns, and MS2 profiles, 108 compounds were putatively identified using the OTCML combined with manual verification, including 12 alkaloids, 49 flavonoids, 13 terpenoids, 14 phenylpropanoids, 4 phenolic acids, 5 phenols, and 11 other phytochemicals. Of these compounds, 17 were confirmed using reference standards. In addition, representative compounds of these different chemical types were used as examples to analyze the fragmentation pathways and characteristic product ions. Moreover, 20 herbs within the QFPD granules were also identified to establish the sources of these chemical components. This is the first rapid profiling of the chemical constituents of QFPD granules using HPLC-Q Exactive Orbitrap-MS and yields valuable information for further quality control and mechanistic studies of QFPD granules.
Supplementary Information
The online version contains supplementary material available at 10.1007/s10337-021-04085-0.
Keywords: Chemical constituent identification, Qingfei Paidu granules, HPLC-Q Exactive Orbitrap-MS, Orbitrap traditional Chinese medicine library
Introduction
Qingfei Paidu (QFPD) granules and decoctions are effective traditional Chinese medicines (TCMs) that are included in the Guidelines for Diagnosis and Treatment of COVID-19 Pneumonia, issued by the National Heath Commission of the People’s Republic of China [1]. QFPD granules and decoctions are based on the following four formulae: Maxing-Shigan-Tang, Wuling-San, Xiaocaihu-Tang, and Shegan-Mahuang-Tang [2], which are different forms of prescription QFPD. QFPD granules contain 20 herbs: Ephedrae Herba, Glycyrrhizae Radix Et Rhizoma Praeparata Cum Melle, Armeniacae Semen Amarum, Cinnamomi Ramulus, Pogostemonis Herba, Alismatis Rhizoma, Polyporus, Atractylodis Macrocephalae Rhizoma, Poria, Bupleuri Radix, Scutellariae Radix, Pinelliae Rhizoma Praeparatum Cum Zingibere Et Alumine, Zingiberis Rhizoma Recens, Asteris Radix Et Rhizoma, Farfarae Flos, Belamcandae Rhizoma, Asari Radix Et Rhizoma, Dioscoreae Rhizoma, Aurantii Fructus Immaturus, and Citri Reticulatae Pericarpium. In addition, QFPD contains the mineral Gypsum Fibrosum.
In China, QFPD granules and decoctions have been widely used to treat patients infected with SARS-CoV-2 owing to positive treatment results. Early treatment with prescription QFPD was associated with favorable patient outcomes and may be an effective strategy for epidemic control [1]. Functional network pharmacology analysis units showed that QFPD protected against COVID-19 through anti-viral and anti-inflammatory activities [2]. A systematic pharmacological study illustrated that QFPD exhibited immune regulation, anti-infection and anti-inflammatory properties, and multi-organ protection [3]. QFPD granules were, therefore, approved for market use by the National Medical Products Administration in China [4]. However, worldwide acceptance of QFPD granules is challenging because of the TCM complexity, and unique theory of treatment, in addition to quality and safety issues [5, 6]. Thus, comprehensive identification of the chemical components of QFPD granules is extremely critical for quality control, in addition to identification of the active ingredients and investigation of the mechanism-of-action.
Few analytical strategies have been applied to study the chemical constituents of QFPD decoctions, and no detailed analysis of the chemical composition of QFPD granules has been reported [7–9]. Hybrid quadrupole-Orbitrap mass spectrometry (MS) is a powerful tool for structure elucidation of TCMs due to its high resolution and high-quality MS2 fragmentation patterns. In this study, high-performance liquid chromatography (HPLC)-Q Exactive Orbitrap-MS was used to analyze the chemical constituents of QFPD granules, with 108 compounds putatively identified, including 12 alkaloids, 49 flavonoids, 13 terpenoids, 14 phenylpropanoids, 4 phenolic acids, 5 phenols, and 11 other phytochemicals. The individual herbs within the QFPD granules were also analyzed. The aim of this study is to develop an analytical method for elucidating the chemical constituents of QFPD granules and provide valuable quality control and mechanism-of-action data.
Material and Methods
Reagents and Materials
QFPD granules were a gift from Renmin Hospital of Wuhan University. The 21 raw materials were purchased from Yifeng Pharmacy Chain Co., Ltd. (Changde, China). Acetonitrile (HPLC grade) and methanol (HPLC grade) were purchased from Merck (Darmstadt, Germany). Formic acid was purchased from Thermo Fisher Scientific (Waltham, MA, USA). Watsons distilled water was obtained from Jingdong Mall (Beijing, China).
Authentic standards of cytosine, sucrose, citric acid, uridine, adenosine, 2-pyrrolidinecarboxylic acid, and guanosine were purchased from Sigma-Aldrich (St. Louis, MO, USA). Nicotinic acid was obtained from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Nicotinamide and tangeretin were purchased from Shanghai Aladdin Bio-Chem Technology Co., Ltd. (Shanghai, China). Salicylic acid was acquired from Ascender Chemical Co., Ltd. (Shanghai, China). Glycyrrhizic acid, 18-β-glycyrrhetinic acid, isoliquiritigenin, baicalin, and narirutin were purchased from Shanghai Macklin Biochemical Co., Ltd. (Shanghai, China). Chlorogenic acid was a gift from Thermo Fisher Scientific.
Standard Solutions and Sample Preparations
The QFPD granules were ground, and the resultant powder (0.4 g) was accurately weighed, dissolved in 60% methanol (v/v; 20 mL), and sonicated for 30 min, resulting in partial precipitation of the QFPD granules. The solution was centrifuged, and the supernatant was filtered through a 0.22 μm membrane prior to HPLC-Q Exactive Orbitrap-MS.
The individual raw materials were treated using the same procedure.
The authentic standards were dissolved in 50% methanol and stored at – 80 ℃. Prior to qualitative analysis, they were mixed appropriate concentrations and filtered using a 0.22 μm membrane.
HPLC-Q Exactive Hybrid Quadrupole-Orbitrap MS
LC–MS was performed using an UltiMate 3000 UPLC system (Thermo Fisher Scientific), autosampler, a vacuum degasser, binary pump, and column compartment. A Hypersil Gold aQ C18 column (2.1 × 150 mm, 3 μm) was used at 40 ℃ for chromatography. The mobile phase consisted of acetonitrile/0.1% formic acid (A) and water/0.1% formic acid (B) at a flow rate of 0.2 mL/min. The following gradient elution program was used: 0–2 min, 0–5% (A); 2–42 min, 5–95% (A); 42–46.9 min, 95% (A); 46.9–47 min, 95–5% (A); 47–50 min, 5% (A). The total run time was 50 min, and the sample injection volume was 5 μL.
A Q Exactive hybrid quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific) with heated electrospray ionization (ESI) was used. Source parameters were optimized with a spray voltage of 3.5 kV ( +)/3.2 kV (−). The other parameters were set as follows: capillary temperature, 320 ℃; auxiliary gas temperature, 350 ℃; sheath gas, 40 Arb; auxiliary gas, 15 Arb; sweep gas, 0 Arb; S-lens RF level, 50.
The Orbitrap mass detector was operated in full scan plus data-dependent MS2 mode. The MS resolution was set at 70,000 for the full scan and 17,500 for the MS2 scan. The automatic gain control target and maximum injection time were 1 × 106 ions capacity and 100 ms, respectively. The top N (N: the number of most abundant ions for fragmentation) was five, while the scan range was m/z 100–1500. The normalized collision energies were 20%, 40%, and 60%, and the isolation window was 1.2 Da. The apex trigger was 5–15 s, and the loop count was 3. The dynamic exclusion was 5 s.
Data Analysis Using the Orbitrap Traditional Chinese Medicine Library (OTCML) and Manual Verification
The raw data were imported into the Compound Discoverer (CD) software, which is integrated into the OTCML. The molecular masses, retention times, fragments, and peak areas from both the positive and negative ESI modes were compared to the mzVault library, which was integrated into CD. The mzVault spectral library (Thermo Fisher Scientific) contained the retention times, precise mass ions, and MS2 fragments of 1200 commercial reference standards, which were analyzed using Q Exactive Orbitrap-MS. The software identified peaks with high mass accuracy (< 10 ppm) and an isotope pattern variation within 85%. The molecular compositions adhered to the H/C ratio rules and were matched to potential compounds using ring and double-bond equivalents. The MS2 profiles were compared with the reference spectra from the mzVault library. Compounds were identified only when the match score was > 85. In addition, compound identification accuracy was improved by comparing the obtained data and possible fragmentation patterns with those in the literature, and the corresponding individual herb pieces components were analyzed to determine the source of each compound and elucidate chemical compositions.
Results and discussion
Positive and negative ion modes were used to detect the chemical compounds within the QFPD granules. The base peak chromatograms (BPCs) of the QFPD granules are shown in Fig. 1. In total, 108 compounds are putatively identified (Table 1). The BPCs of the individual herb pieces are shown in Figs. S1 and S2. Compound identification is summarized below.
Fig. 1.
Base peak chromatograms of QFPD granules obtained using high performance liquid chromatography- Q Exactive hybrid quadrupole-Orbitrap mass spectrometry. A Electrospray ionization in the positive mode (ESI( +)), B electrospray ionization in the negative mode (ESI( −))
Table 1.
Identification of the chemical components of QFPD granules using high performance liquid chromatography-Q Exactive hybrid quadrupole-Orbitrap mass spectrometry combined with the Orbitrap traditional Chinese medicine library
| No. | RT (min) | Formula | Potential compound | Detected m/z | Characterized MS2 | Compound class | Herb | Refs |
|---|---|---|---|---|---|---|---|---|
| 1d | 2.11 | C12H22O11 | Sucrose | 341.1069 [M – H]− |
89.0235 71.1031 59.0132b |
Miscellaneous | PR | [10] |
| 2d | 2.12 | C5H9NO2 | 2-Pyrrolidinecarboxylic acid | 116.0709 [M + H]+ |
116.0708 70.0658b |
Miscellaneous | DR | [11] |
| 3d | 2.12 | C4H5N3O | Cytosine | 112.0508 [M + H]+ |
112.0508b 95.0244 |
Alkaloids | AR | |
| 4 | 2.13 | C5H11NO2 | Betaine | 118.0865 [M + H]+ |
118.0864b 59.0737 |
Alkaloids | AE | |
| 5 | 2.14 | C7H7NO2 | Trigonelline | 138.0550 [M + H]+ |
138.0550b 110.0603 94.0656 |
Alkaloids | PC | [12] |
| 6d | 2.2 | C6H8O7 | Citric acid | 191.0185 [M – H]− |
111.0078b 87.0079 |
Miscellaneous | GR | |
| 7d | 2.66 | C6H5NO2 | Nicotinic acid | 124.0395 [M + H]+ |
124.0394b 96.0448 80.05 |
Alkaloids | ||
| 8acd | 2.69 | C9H12N2O6 | Uridine | 243.0608 [M – H]− |
200.0554 152.0339 122.0234 110.0238b |
Miscellaneous | PR | [13] |
| 9d | 2.69 | C6H6N2O | Nicotinamide | 123.0555 [M + H]+ |
123.0554b 96.0448 80.0501 |
Alkaloids | FF | |
| 10ad | 2.73 | C10H13N5O4 | Adenosine | 268.1041 [M + H]+ | 136.0618b | Miscellaneous | PC | [14] |
| 11acd | 2.87 | C10H13N5O5 | Guanosine | 284.0989 [M + H]+ | 152.0567b | Miscellaneous | PC | [14] |
| 12 | 3.41 | C7H6O5 | Gallic acid | 169.013 [M – H]− |
125.0233b 97.0285 69.0337 |
Phenolic acids | ||
| 13 | 3.9 | C9H11NO2 | l-Phenylalanine | 166.0863[M + H]+ |
120.0809b 103.0546 |
Miscellaneous | ||
| 14 | 4.22 | C6H6O3 | 5-Hydroxymethylfurfural | 127.0392 [M + H]+ |
109.0288b 81.0341 |
Miscellaneous | PC | [15] |
| 15 | 4.68 | C9H13NO | l-norephedrine | 152.1069 [M + H]+ |
134.0965b 117.0701 |
Alkaloids | EH | [16] |
| 16 | 5.12 | C9H13NO | d-norpseudoephedrine | 152.1069 [M + H]+ |
134.0965b 117.0701 |
Alkaloids | EH | [16] |
| 17 | 5.24 | C15H14O7 | ( −)-Gallocatechin | 305.0651 [M – H]− |
219.0654 137.0232 125.0232b |
Phenols | ||
| 18 | 5.32 | C7H6O4 | Protocatechuic acid | 153.0181 [M – H]− | 109.0284b | Phenolic acids | GR | [15] |
| 19 | 6.09 | C10H15NO | l-ephedrine | 166.1226 [M + H]+ |
148.1120b 133.0887 117.0701 91.0547 |
Alkaloids | EH | [16] |
| 20 | 6.47 | C10H15NO | d-pseudoephedrine | 166.1226 [M + H]+ |
148.1120b 133.0887 117.0701 91.0547 |
Alkaloids | EH | [16] |
| 21 | 6.99 | C11H17NO | Methylephedrine | 180.1382 [M + H]+ |
162.1276b 147.1041 135.0805 117.0701 |
Alkaloids | EH | [16] |
| 22 | 7.26 | C7H6O3 | Protocatechualdehyde | 137.0233 [M – H]− |
137.0233b 119.0126 109.0285 |
Phenols | CR | [15] |
| 23c | 9.16 | C20H27NO11 | Amygdalin | 456.1492 [M – H]− |
323.0963 221.0653 161.0443 59.0132b |
Miscellaneous | AS | [17] |
| 24 cd | 9.43 | C16H18O9 | Chlorogenic acid | 353.0862 [M – H]− |
191.0548b 135.0441 179.0337 |
Phenylpropanoids | FF | [18] |
| 25 | 9.46 | C9H6O4 | Esculetin | 177.0181 [M – H]− |
177.0180b 149.0236 133.0284 105.0336 |
Phenylpropanoids | ||
| 26 | 9.48 | C7H6O2 | p-Hydroxybenzaldehyde | 121.0285 [M – H]− |
121.0284b 93.0336 |
Phenols | ||
| 27 | 9.78 | C9H8O4 | Caffeic acid | 179.0337 [M – H]− | 135.0441b | Phenolic acids | ||
| 28a | 10.49 | C15H14O6 | Catechin hydrate | 289.0703 [M – H]− |
245.0805 123.044 109.0284b |
Flavonoids | ||
| 29a | 10.63 | C15H12O7 | Taxifolin | 303.0494 [M – H]− |
177.018 125.0233b |
Flavonoids | SR | [19] |
| 30c | 10.98 | C27H30O15 | Vicenin II | 593.1482 [M – H]− |
353.0648b 383.0753 473.1062 297.075 |
Flavonoids | GR | [8] |
| 31 | 11.12 | C25H24O12 | 1,3-Dicaffeoylquinic acid | 515.1168 [M – H]− |
353.0859 191.0547b 179.0336 135.044 |
Phenylpropanoids | ||
| 32 | 11.87 | C9H8O3 | p-Coumaric acid | 163.0400 [M – H]− |
119.0496b 163.0394 |
Phenylpropanoids | ||
| 33ac | 11.95 | C26H28O14 | Isoschaftoside | 563.1376 [M – H]− |
353.0648b 383.0754 473.1073 |
Flavonoids | GR | [20] |
| 34 | 11.96 | C9H10O4 | 3,5-Dimethoxy-4-hydroxybenzaldehyde | 183.0652 [M + H]+ |
140.0469 123.0443 95.0497b |
Phenols |
CR EH RE |
[15] |
| 35 | 12.18 | C21H20O11 | Orientin | 447.0913 [M – H]− |
357.06 327.0496b 299.0541 133.028 |
Alkaloids | CP | [21] |
| 36 | 12.6 | C10H8O4 | Scopoletin | 193.0497 [M + H]+ |
193.0496b 178.026 133.0285 |
Phenylpropanoids | AF | [22] |
| 37ac | 12.7 | C26H30O13 | Naringenin 7-O-(2-β-d-apiofuranosyl)-β-d-glucopyranoside | 549.1588 [M – H]− |
255.0649 135.0077 119.0492b |
Flavonoids | GR | [20] |
| 38 | 12.84 | C10H10O4 | Ferulic acid | 193.0492 [M – H]− |
178.0258 134.0362b |
Phenylpropanoids | ||
| 39 | 13.03 | C11H10O5 | Isofraxidin | 223.0601 [M + H]+ |
223.0601b 190.0261 162.0311 |
Phenylpropanoids | ||
| 40c | 13.04 | C27H32O15 | Eriocitrin | 595.1638 [M – H]− |
459.1152 151.0025b 135.0441 |
Flavonoids |
CP AF |
[21] [23] |
| 41c | 13.04 | C26H30O13 | Liquiritin apioside | 549.1586 [M – H]− |
119.0491b 135.0077 255.0649 |
Flavonoids | GR | [20] |
| 42c | 13.18 | C27H30O16 | Rutin | 609.1431[M – H]− |
300.0258b 271.0234 255.0284 |
Flavonoids | ||
| 43 | 13.39 | C9H6O4 | 5,7-Dihydroxychromone | 177.0180 [M – H]− |
177.0180b 135.0076 |
Flavonoids | ||
| 44d | 13.75 | C7H6O3 | Salicylic acid | 137.0233 [M – H]− |
137.0233 93.0337b |
Phenolic acids | AE | [15] |
| 45 | 13.8 | C14H12O4 | Piceatannol | 243.0648 [M – H]− |
243.0648b 201.0544 159.0439 |
Phenols | ||
| 46 | 13.84 | C25H24O12 | Isochlorogenic acid B | 515.1165 [M – H]− |
353.0856 191.0547 179.0336 135.0440b |
Phenylpropanoids | FF | [18] |
| 47 cd | 13.89 | C27H32O14 | Narirutin | 581.1863 [M + H]+ |
273.0755b 153.0181 85.0289 71.0498 |
Flavonoids | CP | [21] |
| 48a | 14.02 | C29H36O15 | Verbascoside | 623.1945 [M – H]− |
461.1639 161.0231b 133.0283 |
Phenylpropanoids | PH | [15] |
| 49 | 14.13 | C25H24O12 | 3,5-Dicaffeoylquinic acid | 515.1165 [M – H]− |
353.0878 191.0558b 179.0346 135.0448 |
Phenylpropanoids | FF | [18] |
| 50 | 14.14 | C22H22O11 | Tectoridin | 463.1234 [M + H]+ |
301.0705b 286.047 |
Flavonoids | BH |
[24] [25] |
| 51ac | 14.27 | C27H32O14 | Naringin | 579.1688 [M – H]− |
271.0597 151.0025b 119.0491 107.0129 |
Flavonoids |
AF CP |
[23] [21] |
| 52 | 14.57 | C9H16O4 | Azelaic acid | 187.0962[M – H]− |
125.0960b 97.0649 |
Miscellaneous | ||
| 53 | 14.62 | C28H34O15 | Neohesperidin | 609.1796 [M – H]− |
609.1791 301.0700b 286.0466 |
Flavonoids | CP | |
| 54 | 14.95 | C25H24O12 | Isochlorogenic acid C | 515.1166 [M – H]− |
353.088 191.0558 173.0452 135.0448b |
Phenylpropanoids | FF | [18] |
| 55c | 15 | C28H34O15 | Hesperidin | 609.1796 [M – H]− |
609.1791 301.0699b 286.0466 |
Flavonoids | CP | [26] |
| 56 | 15.06 | C24H26O13 | Iridin | 523.1445 [M + H]+ |
361.0915b 346.0679 331.0445 |
Flavonoids | BH | [25] |
| 57 | 15.06 | C9H6O2 | Coumarin | 147.0440 [M + H]+ |
147.0440b 103.0546 91.0547 |
Phenylpropanoids |
CR EH |
[15] |
| 58a | 15.63 | C15H12O6 | Eriodictyol | 287.0547 [M – H]− |
287.0547 161.0231 125.0233b |
Flavonoids | AF | [23] |
| 59c | 15.86 | C26H30O13 | Isoliquiritin apioside | 549.1589 [M – H]− |
255.0649 153.0181 135.0077 119.0491b |
Flavonoids | GR | [20] |
| 60 | 16.06 | C22H22O9 | Ononin | 431.1336 [M + H]+ |
269.0807b 254.0573 237.0544 |
Flavonoids | GR | [27] |
| 61 cd | 16.08 | C21H18O11 | Baicalin | 445.0753 [M – H]− | 269.0439b | Flavonoids | SR | [19] |
| 62 | 16.15 | C21H20O10 | Oroxin A | 433.1129 [M + H]+ |
271.0599b 253.0493 123.0078 |
Flavonoids | SR | [19] |
| 63a | 16.23 | C21H22O9 | Isoliquiritin | 419.1334 [M + H]+ |
257.0806b 147.0439 137.0232 |
Flavonoids | GR | [20] |
| 64c | 16.51 | C15H12O4 | Liquiritigenin | 255.0651 [M – H]− |
135.0078 119.0492b 91.0181 |
Flavonoids | GR | [20] |
| 65 | 16.87 | C11H6O4 | Bergaptol | 201.0180 [M – H]− |
201.0192b 183.1012 139.1117 |
Phenylpropanoids | ||
| 66c | 16.92 | C21H18O11 | Norwogonin-8-glucuronide | 445.0753 [M – H]− | 269.0441b | Flavonoids | SR | [19] |
| 67 | 17.2 | C28H34O14 | Poncirin | 593.1842 [M – H]− |
593.184 285.0753b 151.0024 |
Flavonoids | AF | [23] |
| 68 | 17.24 | C21H18O11 | Norwogonin-7-glucuronide | 445.0752 [M – H]− | 269.0439b | Flavonoids | SR | [19] |
| 69c | 17.51 | C22H20O11 | Oroxylin A-7-O-β-d-glucuronide | 459.0910 [M – H]− |
283.0595 268.0362b |
Flavonoids | SR | [19] |
| 70c | 18.11 | C21H18O11 | Baicalein-6-glucuronide | 445.0754 [M – H]− | 269.0441b | Flavonoids | SR | [19] |
| 71c | 18.14 | C22H20O11 | Wogonoside | 459.0909 [M – H]− |
283.0595 268.0362b |
Flavonoids | SR | [19] |
| 72 | 18.58 | C15H12O5 | Naringenin chalcone | 273.0756 [M + H]+ |
273.0757 153.0182b 147.044 119.0493 |
Flavonoids |
GR AF CP |
[20] [23] [21] |
| 73c | 19.32 | C16H14O6 | Hesperetin | 301.0702 [M – H]− |
301.0702b 286.044 164.0103 108.0207 |
Flavonoids | CP | [26] |
| 74 | 19.38 | C16H12O6 | Tectorigenin | 299.0546[M – H]− |
284.0301b 240.0414 |
Flavonoids | ||
| 75ac | 20.01 | C18H16O8 | Irigenin | 359.0756 [M – H]− |
344.0519 329.0286b 314.0054 286.0104 |
Flavonoids | BH | [24] |
| 76 | 20.03 | C16H12O7 | Isorhamnetin | 315.0496 [M – H]− |
315.0496 300.0260b 271.0237 151.002 |
Flavonoids | AE | [28] |
| 77c | 20.15 | C17H14O7 | Iristectorigenin B | 329.0652 [M – H]− |
314.0417 299.0180b 271.0235 |
Flavonoids | BH | [24] |
| 78 | 20.39 | C15H10O5 | Baicalein | 269.0443 [M – H]− |
269.0457b 241.0507 223.0398 |
Flavonoids | SR | [19] |
| 79 cd | 20.97 | C15H12O4 | Isoliquiritigenin | 255.0650 [M – H]− |
135.0076 119.0491b 91.018 |
Flavonoids | GR | [20] |
| 80 | 21.08 | C16H12O4 | Formononetin | 269.0807 [M + H]+ |
269.0807b 254.0574 |
Flavonoids | GR | [20] |
| 81ac | 21.35 | C15H16O4 | Isomeranzin | 261.1119 [M + H]+ |
189.0546b 159.0439 131.0492 |
Phenylpropanoids | ||
| 82ac | 21.65 | C42H62O17 | Licorice-saponin G2 | 837.3869 [M – H]− |
837.386 351.0552 193.0341 113.0235b |
Terpenoids | GR | [20] |
| 83c | 21.83 | C26H30O8 | Limonin | 469.1846 [M – H]− |
469.1831b 249.0909 229.1214 |
Terpenoids | AF | [22] |
| 84 | 21.83 | C15H22O2 | Curcumenol | 235.1693 [M + H]+ |
235.169 217.1588 199.1482b |
Terpenoids | ||
| 85 | 22.15 | C20H20O7 | Isosinensetin | 373.1283 [M + H]+ |
373.1281b 343.0812 |
Flavonoids | CP | [26] |
| 86 cd | 22.64 | C30H46O4 | 18 β-Glycyrrhetinic acid | 471.3469 [M + H]+ |
417.3471b 453.3362 |
Terpenoids | GR | [29] |
| 87 cd | 22.65 | C42H62O16 | Glycyrrhizic acid | 821.3926 [M – H]− |
821.3915b 351.056 113.0234 |
Terpenoids | GR | [20] |
| 88 | 22.72 | C20H18O8 | Irisflorentin | 387.1073 [M + H]+ |
387.1073b 372.0843 357.0603 329.0654 |
Flavonoids | BH | [25] |
| 89 | 22.84 | C20H20O7 | Sinensetin | 373.1282 [M + H]+ |
373.1281b 343.0809 |
Flavonoids | CP | [26] |
| 90 | 22.98 | C18H14O8 | Dichotomitin | 359.0762 [M + H]+ |
359.0761b 344.0526 326.0421 299.0549 |
Flavonoids | BH | [24] |
| 91a | 23.16 | C16H12O5 | Wogonin | 285.0757 [M + H]+ |
285.0756 270.0521b |
Flavonoids | SR | [19] |
| 92 | 23.34 | C42H62O16 | isomer of Glycyrrhizic acid | 821.3922 [M – H]− |
821.3919b 351.0551 113.0235 |
Terpenoids | GR | |
| 93c | 23.57 | C42H68O13 | Saikosaponin A | 825.4599 [M + COOH]− |
779.4534b 617.40106 59.0132 |
Terpenoids | BR | [26] |
| 94 | 23.91 | C17H14O6 | Pectolinarigenin | 313.0703 [M – H]− |
313.0701 283.0233b 255.0286 |
Flavonoids | SR | [19] |
| 95 | 23.99 | C21H22O8 | Nobiletin | 403.1388 [M + H]+ |
403.1388 373.0917b 211.0238 183.0288 |
Flavonoids | CP | [26] |
| 96a | 24.04 | C19H18O6 | 6-Demethoxytangeretin | 343.1174 [M + H]+ |
343.1173 313.0705b 285.0756 |
Flavonoids | CP | [26] |
| 97c | 24.09 | C42H68O13 | Saikosaponin B1 | 825.4599 [M + COOH]− |
779.4542b 617.4028 59.0132 |
Terpenoids | BR | |
| 98a | 24.13 | C16H12O5 | Oroxylin A | 285.0758 [M + H]+ |
285.0757 270.0523b 168.0054 |
Flavonoids | SR | [19] |
| 99 | 24.21 | C15H20O3 | Atractylenolide III | 249.1486 [M + H]+ |
231.1379b 249.1481 213.1276 163.0752 |
Terpenoids | AM | [30] |
| 100 | 24.49 | C22H24O9 | Heptamethoxyflavone | 433.1493 [M + H]+ |
403.1021 433.1492b 165.0546 |
Flavonoids | CP | [26] |
| 101c | 24.7 | C42H68O13 | Saikosaponin D | 825.4594 [M + COOH]− |
779.4537b 617.4034 59.0132 |
Terpenoids | BR | |
| 102d | 25.67 | C20H20O7 | Tangeretin | 373.1280 [M + H]+ |
373.1278 358.1043 343.0808b 328.0573 |
Flavonoids | CP | [26] |
| 103 | 26.41 | C20H20O8 | 5-O-Demethylnobiletin | 389.1230 [M + H]+ |
389.1227b 359.076 341.0652 |
Flavonoids | CP | [21] |
| 104 | 26.68 | C32H48O6 | Alisol C 23-acetate | 529.3526 [M + H]+ |
529.3521b 469.3314 451.3204 415.2842 |
Terpenoids | AR | [31] |
| 105 | 27.85 | C15H20O2 | Atractylenolide II | 233.1536 [M + H]+ |
233.1536b 215.1432 187.1482 151.0753 |
Terpenoids | AM | [30] |
| 106 | 27.94 | C12H16O4 | Pogostone | 225.1122 [M + H]+ |
207.1015 139.039 81.0705b |
Miscellaneous | PH | [32] |
| 107 | 34.7 | C32H50O5 | Alisol B 23-acetate | 515.3733 [M + H]+ |
437.3412 339.2679 419.3305 97.0653b |
Terpenoids | AR | [31] |
| 108 | 35.79 | C18H30O2 | α-Linolenic acid | 279.2318 [M + H]+ |
95.086 81.0705 67.055b |
Alkaloids |
RT retention time
aRepresentative retention time, as more than one peak was identified for this compound
bBase fragment ion
cCompounds detected using both the positive and negative electrospray ionization modes. m/z: mass-to-charge ratio
dCompounds identified by comparison with reference standards. Herb: Compound detected within herb experimentally and also the reference reported the source of the compound. Ref.: The references that reported the sources of the compounds. EH (Ephedrae Herba), GR (Glycyrrhizae Radix Et Rhizoma Praeparata Cum Melle), AS (Armeniacae Semen Amarum), CR (Cinnamomi Ramulus), PH (Pogostemonis Herba), AR (Alismatis Rhizoma), PP (Polyporus), AM (Atractylodis Macrocephalae Rhizoma), PR (Poria), BR (Bupleuri Radix), SR (Scutellariae Radix); PC (Pinelliae Rhizoma Praeparatum Cum Zingibere Et Alumine), ZR (Zingiberis Rhizoma Recens), AE (Asteris Radix Et Rhizoma), FF (Farfarae Flos), BH (Belamcandae Rhizoma), RE (Asari Radix Et Rhizoma), DR (Dioscoreae Rhizoma), AF (Aurantii Fructus Immaturus); CP (Citri Reticulatae Pericarpium)
Alkaloids
Twelve alkaloids were detected. Compounds 19, 20, 21, 15, and 16 are observed in the positive BPC of QFPD, with no matching identification results after data processing using the OTCML. The mass spectra of compounds 15, 19, and 21 display the same fragment ions at m/z 117.0701 (Fig. S3). The mass spectra of compounds 19 and 20 exhibit the same [M + H]+ ions at m/z 166.1226 (C10H15NO), with the same fragment ions also observed at m/z 148.1120 [M + H – H2O]+ and 133.0887 [M + H – H2O – CH3]+. According to the literature [16], they are identified as L-ephedrine (19) and D-pseudoephedrine (20). The mass spectrum of compound 21 (methylephedrine) reveals a peak representing the protonated molecule [M + H]+, at m/z 180.1382, and fragment ion peaks at m/z 162.1276 [M + H – H2O]+ and 147.1041 [M + H – H2O – CH3]+. The mass spectra of compounds 15 (l-norephedrine) and 16 (D-norpseudoephedrine) reveal the same peak at m/z 152.1069, and MS2 peaks at m/z 134.0965 [M + H – H2O]+ and 117.0701 [M + H – H2O – NH3]+. However, they exhibit different retention times. These compounds are phytochemicals present in Ephedrae Herba.
Compounds 3 (cytosine), 7 (nicotinic acid), and 9 (nicotinamide) were identified by comparing the retention times and MS2 fragmentation patterns with those of reference standards. Nicotinic acid and nicotinamide exhibit the same structural skeleton, and fragment ion peaks at m/z 96.0448 [M + H – CO]+ are observed in the MS2 profiles. Their possible fragmentation pathways and library match results are shown in Fig. S4. The MS2 profile of compound 5 reveals a peak representing a protonated molecule, [M + H]+, at m/z 138.0550 and peaks at m/z 110.0603 [M + H − CO]+ and 94.0656 [M + H − CO − O]+. Therefore, compound 5 is deduced to be trigonelline.
Flavonoids
Forty-nine compounds were identified as flavonoids. Compounds 47 and 51 were identified as narirutin and naringin, respectively, by comparison with the OTCML. Furthermore, compound 47 was confirmed using a reference standard. They were detected in both the positive and negative ESI modes, displaying similar MS and MS2 profiles that revealed peaks representing [M − H]− ions at m/z 579.1688. Fragment ions were represented by peaks at m/z 271.0615, owing to the loss of glucose (Glc) and rhamnose moieties [21]. Characterized fragment ions represented by peaks at m/z 151.0034 and 119.0499 were generated by retro-Diels–Alder cleavage. Narirutin and naringin are flavonoid O-glycoside isomers distinguished by their different retention times. Compounds 87 (isosinensetin), 89 (sinensetin), 96 (6-demethoxytangeretin), 95 (nobiletin), and 102 (tangeretin) are polymethoxyflavones, bearing numerous methoxyl and/or hydroxyl groups on the basic structure. The mass spectra of these compounds show peaks representing [M + H]+ ions and characterized fragment ions due to continuous CH3 loss [26]. The MS2 profiles and library match results are shown in Fig. S5. As examples, the mass spectra of compounds 85 and 89 reveal peaks representing [M + H]+ ions at m/z 373.1283 and characterized fragment ions at m/z 343.08 [M + H − 2CH3]+. The spectra are very similar, and the compounds were identified using the OTCML by the different retention times and slight differences in the spectra. Compound 102 (tangeretin) was further confirmed using a reference standard. Compounds 30 and 33 showed similar MS2 patterns, but the molecular ions were different, indicating the same basic structure. These compounds were assigned as vicenin II [8] and isoschaftoside [20, 33], respectively. For example, the mass spectrum of compound 30 revealed peaks representing the [M − H]− ion at m/z 593.1482 and fragment ions at m/z 297.0750 [M − H − Glc − Glc]−, m/z 473.1062 [M − H − 120]−, m/z 383.0753 [M – H – 210]−, and m/z 353.0648 [M − H − 240]−. These are characterized fragment ions of the hexose ring-opening reaction [33]. The similarities of the MS and MS2 profiles of compounds 37, 41, and 59 indicated isomers. By comparing the data in the OTCML combined with literature data [20], they were deduced as naringenin 7-O-(2-β-d-apiofuranosyl)-β-d-glucopyranoside (37), liquiritin apioside (41), and isoliquiritin apioside (59). The mass spectra of compounds 61, 68, 66, and 70 revealed peaks representing [M − H]− ions at m/z 445.07 and dominant fragment ions at m/z 269.04, along with [M + H]+ ions at m/z 447.09 and dominant fragment ions at m/z 271.05. Individual herb pieces component mass spectra showed that these compounds, baicalin (61), norwogonin-7-glucuronide (68), norwogonin-8-glucuronide (66) and baicalein-6-glucuronide (70), were chemical components of Scutellariae Radix [19], and baicalin (61) was identified using a reference standard. Based on the literature [26], compounds 73 and 100 were assigned as hesperetin and heptamethoxyflavone, respectively. Compound 79 (isoliquiritigenin) was identified using a reference standard.
Phenylpropanoids
Fourteen compounds were identified as phenylpropanoids. Compounds 31 (1,3-dicaffeoylquinic acid), 46 (isochlorogenic acid B), 49 (3,5-dicaffeoylquinic acid) and 53 (isochlorogenic acid C) were identified using the OTCML. Compound 24 (chlorogenic acid) was identified using a reference standard. Compounds 31, 46, 49 and 53 were isomers with skeletons similar to those of quinic and caffeic acid, generating similar MS and MS2 profiles and distinguished by their retention times. For example, the MS2 profile of compound 46 revealed peaks representing fragment ions at m/z 191.0547 [quinic acid − H]−, 179.0336 [caffeic acid − H]− and 135.0440 [caffeic acid − CO2 − H]−. The mass spectrum of compound 38 (ferulic acid) showed peaks representing a [M – H]− ion at m/z 193.0492 and the main fragment ions at m/z 134.0362 [M − H − CH3 − CO2]− and 178.0258 [M − H − CH3]−. Compounds 32 (p-coumaric acid), 57 (coumarin), 65 (bergaptol) and 25 (esculetin) were assigned using the OTCML.
Phenolic Acids and Phenols
Four phenolic acids were identified, and they exhibited the same fragmentation pattern. The MS2 profile of compound 12 (gallic acid) revealed peaks representing [M − H]− at m/z 169.0130 and ions at m/z 125.0233 [M − H − CO2]−, 97.0285 [M − H − CO2 − CO]− and 69.0337 [M − H − CO2 − CO − CO]−. The mass spectrum of compound 18 (protocatechuic acid) revealed a peak representing a base fragment ion at m/z 109.0284 [M − H − CO2]−. Compound 44 (salicylic acid) was identified by comparison with a reference standard. All of these compounds exhibited successive losses of H2O, CO and CO2 during fragmentation [34, 35].
Five phenols were identified. Compound 26 (p-hydroxybenzaldehyde) produced several clear fragment ions at high collision energies. Compound 22 (protocatechualdehyde) was identified using the OTCML. The phenols also showed neutral losses of CO, CH3 and H2O in the MS2 profiles.
Terpenoids
Thirteen terpenoids are identified. The mass spectra of compounds 82 and 87 reveal peaks representing [M + H]+ ions at m/z 839.4061 and 823.4108, respectively. The mass spectrum of compound 82 (licorice-saponin G2) reveals peaks representing fragment ions at m/z 469.3314 [Aglycone + H − H2O]+, 487.3412 [Aglycone + H]+ and 451.3212 [Aglycone + H − 2H2O]+ [36]. Compound 87 displays a similar fragmentation pattern, yet is 16 Da smaller than compound 82. Compound 87 was then confirmed as glycyrrhizic acid through a comparison between the negative ESI mode data, a reference standard, and literature data [20]. These spectra are shown in Fig.S6. The mass spectrum of compound 86, 18 β-glycyrrhetinic acid, reveals a peak representing [M + H]+ at m/z 471.3469. These are triterpenic acids. Compound 86 (18 β-glycyrrhetinic acid) was also identified using a reference standard.
The MS2 profile of compound 104 showed peaks representing a protonated molecule, [M + H]+, at m/z 529.3526 and dominant fragment ions at m/z 529.3521 [M + H]+, 469.3314 [M + H − HAc]+, 451.3204 [M + H – HAc − H2O]+ and 415.2842 [M + H − C4H8O − H2O]+ [31]. This compound was identified as alisol C 23-acetate using the OTCML. The mass spectrum of compound 107, alisol B 23-acetate, revealed a peak representing [M + H]+ at m/z 515.3733.
The mass spectrum of compound 93 revealed peaks representing a [M + H]+ ion at m/z 781.4732 and fragment ions at m/z 455.3518 [M + H − H2O − Fuc (fucose) Glc]+ and 437.3412 [M + H − 2H2O − FucGlc]+. This compound was identified as saikosaponin A by comparison with data obtained from the OTCML. The mass spectrum of compound 83 exhibited peaks representing [M + H]+ at m/z 471.2016 and fragment ions at m/z 425.1957 [M + H − 46]+ and 161.0597. According to the literature [23] and the data in the OTCML, it was limonin.
The mass spectra of compounds 99 and 105 revealed peaks representing [M + H]+ ions at m/z 249.1486 and 233.1536, respectively. They were identified as atractylenolide III and atractylenolide II, respectively, using the OTCML. The MS2 profile of atractylenolide III revealed peaks representing fragment ions at m/z 249.1481 [M + H]+, 231.1379 [M + H − H2O]+, 213.1276 [M + H − 2H2O]+ and 203.1430 [M + H − H2O − CO]+ [30].
Other Phytochemicals
Eleven compounds were identified by comparing the obtained data to the information in the OTCML, including the hydrophilic compounds 1 (sucrose), 2 (2-pyrrolidinecarboxylic acid), 6 (citric acid), 8 (uridine), 10 (adenosine) and 11 (guanosine). These compounds were also confirmed using reference standards.
Quantification Analysis
The extracted ion chromatograms (EICs) of 17 authentic standards compared with those of their corresponding detected compounds within QFPD granules are shown in Fig. 2. The HPLC-Q Exactive hybrid quadrupole-Orbitrap MS method was also used for quantification analysis of these 17 constituents within QFPD granules. The concentration of each constituent was obtained using the respective calibration curve and their contents within the QFPD granules are listed in Table 2.
Fig. 2.
Extracted ion chromatograms (EICs) of 17 authentic standards compared with those of the corresponding compounds detected within QFPD granules. A EICs of compounds 3, 11, and 24; B EICs of compounds 7, 44, and 9; C EICs of compounds 8, 86, and 79; D EICs of compounds 1, 102, and 47; E EICs of compounds 2, 6, and 61; F EICs of compounds 10 and 87. R sample from the QFPD granules, S authentic standards
Table 2.
Contents of the constituents within QFPD granules
| No | Compound | Conc.(mg/g) |
|---|---|---|
| 1 | Sucrose | 0.683 ± 0.185 |
| 2 | 2-Pyrrolidinecarboxylic acid | 0.803 ± 0.017 |
| 3 | Cytosine | 0.009 ± 0.0008 |
| 6 | Citric acid | 4.309 ± 0.352 |
| 7 | Nicotinic acid | 0.011 ± 0.0007 |
| 8 | Uridine | 0.029 ± 0.005 |
| 9 | Nicotinamide | 0.006 ± 0.0003 |
| 10 | Adenosine | 0.164 ± 0.009 |
| 11 | Guanosine | 0.135 ± 0.004 |
| 24 | Chlorogenic acid | 0.854 ± 0.015 |
| 44 | Salicylic acid | 0.016 ± 0.002 |
| 47 | Narirutin | 0.699 ± 0.119 |
| 61 | Baicalin | 4.383 ± 1.107 |
| 79 | Isoliquiritigenin | 0.007 ± 0.00005 |
| 86 | 18 β-Glycyrrhetinic Acid | 0.0005 ± 0.000007 |
| 87 | Glycyrrhizic acid | 2.199 ± 0.127 |
| 102 | Tangeretin | 0.003 ± 0.0003 |
Data present the (average ± standard deviation) of three replicates. Conc. (mg/g): mg of the constituent/ g of QFPD granules
Compounds from Individual Herbs Within QFPD Granules
In total, 265 compounds were putatively identified using the OTCML combined with manual verification from 20 herbs that are components of QFPD granules (Table S1), including 33 alkaloids, 106 flavonoids, 28 terpenoids, 41 phenylpropanoids, 10 phenolic acids, 18 phenols and 29 other phytochemicals. Of these, 163 compounds were from only one herb, and 102 compounds were from more than two herbs. Within the QFPD granules, 59 compounds were from only one herb and 49 compounds were from more than two herbs.
Conclusions
In this study, HPLC-Q Exactive hybrid quadrupole-Orbitrap MS coupled with the OTCML which is an automatic data analysis platform, was used to study the chemical profile of QFPD granules, an effective TCM prescribed to treat the symptoms of SARS-CoV-2 infections. Furthermore, manual verification ensured compound identification. A total of 108 compounds were putatively identified from QFPD granules, including alkaloids, flavonoids, phenylpropanoids, phenolic acids, phenols, terpenoids and other phytochemicals. This allowed rapid chemical composition screening of QFPD granules, providing potentially valuable information for quality control and further clinical application.
Supplementary Information
Below is the link to the electronic supplementary material.
Acknowledgements
This work was financially supported by the National Key R&D Program of China (No. 2018YFA0900400), and the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (No.2020-PT320-004).
Declarations
Conflict of Interest
The authors declare that there are no conflicts of interest.
Ethical Statement
We certify that this manuscript is original, has not been previously published and will not be submitted elsewhere for publication while under consideration by Chromatographia. This study is not split into several parts and submitted to various journals. Results are presented clearly, honestly and without fabrication. No data, text, or theories by others are presented as our own.
Human and Animal Rights
Explicit permission to submit has been received from all co-authors. All the authors whose name appear on the submission have contributed sufficiently to this study.
This manuscript does not contain any studies involving humans or animals.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Shuai Fu and Rongrong Cheng authors contributed equally.
References
- 1.Shi N, Liu B, Liang N, Ma Y, Ge Y, Yi H, Wo H, Gu H, Kuang Y, Tang S, Zhao Y, Tong L, Liu S, Zhao C, Chen R, Bai W, Fan Y, Shi Z, Li L, Liu J, Gu H, Zhi Y, Wang Z, Li Y, Li H, Wang J, Jiao L, Tian Y, Xiong Y, Huo R, Zhang X, Bai J, Chen H, Chen L, Feng Q, Guo T, Hou Y, Hu G, Hu X, Hu Y, Huang J, Huang Q, Huang S, Ji L, Jin H, Lei X, Li C, Wu G, Li J, Li M, Li Q, Li X, Liu H, Liu J, Liu Z, Ma Y, Mao Y, Mo L, Na H, Wang J, Song F, Sun S, Wang D, Wang M, Wang X, Wang Y, Wang Y, Wu W, Wu L, Xiao Y, Xie H, Xu H, Xu S, Xue R, Yang C, Yang K, Yang P, Yuan S, Zhang G, Zhang J, Zhang L, Zhao S, Zhao W, Zheng K, Zhou Y, Zhu J, Zhu T, Li G, Wang W, Zhang H, Wang Y, Wang Y. Pharmacol Res. 2020;161:105290. doi: 10.1016/j.phrs.2020.105290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Chen J, Wang YK, Gao Y, Hu LS, Yang JW, Wang JR, Sun WJ, Liang ZQ, Cao YM, Cao YB. Biomed Pharmacother. 2020;129:110281. doi: 10.1016/j.biopha.2020.110281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Zhao J, Tian S, Lu D, Yang J, Zeng H, Zhang F, Tu D, Ge G, Zheng Y, Shi T, Xu X, Zhao S, Yang Y, Zhang W. Phytomedicine. 2020 doi: 10.1016/j.phymed.2020.153315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.National Medical Products Administration. https://www.nmpa.gov.cn/zhuanti/yqyjzxd/yqyjxd/20210302190503177.html.
- 5.Li Y, Shen Y, Yao CL, Guo DA. J Pharm Biomed Anal. 2020;185:113215. doi: 10.1016/j.jpba.2020.113215. [DOI] [PubMed] [Google Scholar]
- 6.Liu C, Guo DA, Liu L. Phytomedicine. 2018;44:247–257. doi: 10.1016/j.phymed.2018.03.006. [DOI] [PubMed] [Google Scholar]
- 7.Yang R, Liu H, Bai C, Wang Y, Zhang X, Guo R, Wu S, Wang J, Leung E, Chang H, Li P, Liu T, Wang Y. Pharmacol Res. 2020;157:104820. doi: 10.1016/j.phrs.2020.104820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Zhou YY, Gao WY, Gu XR, Chen ZQ, Zhao HY, Bian BL, Yang LX, Si N, Wang HJ, Tan Y. China J Chin Materia Med. 2020;45:3035–3044. doi: 10.19540/j.cnki.cjcmm.20200423.202. [DOI] [PubMed] [Google Scholar]
- 9.Zhang F, Huang J, Liu W, Wang CR, Liu YF, Tu DZ, Liang XM, Yang L, Zhang WD, Chen HZ, Ge GB. Food Chem Toxicol. 2021;149:111998. doi: 10.1016/j.fct.2021.111998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Zhang Y, Cheng Y, Liu Z, Ding L, Qiu T, Chai L, Qiu F, Wang Z, Xiao W, Zhao L, Chen X. J Chromatogr B. 2017;1061–1062:474–486. doi: 10.1016/j.jchromb.2017.07.021. [DOI] [PubMed] [Google Scholar]
- 11.Chen MY, Liu W, Chou GX, Wang YL. Acta Chin Med Pharmacol. 2020;48:62–66. doi: 10.19664/j.cnki.1002-2392.200035. [DOI] [Google Scholar]
- 12.Zhang JY, Zhang XJ, Sun YK. Chin J Inform TCM. 2014;21:71–73. doi: 10.3969/j.issn.1005-5304.2014.05.022. [DOI] [Google Scholar]
- 13.Liu J, Xu YH, Zhang QQ, Zhu MH, Zhu ML, Zhou J. Chin Tradit Patent Med. 2020;42:2003–2008. doi: 10.3969/j.issn.1001-1528.2020.08.008. [DOI] [Google Scholar]
- 14.Yang BY, Li M, Jing Y, Lai YY, Liu JL, Peng L. Chin Tradit Herb Drugs. 2018;49:4349–4355. doi: 10.7501/j.issn.0253-2670.2018.18.020. [DOI] [Google Scholar]
- 15.Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, Compilation prepared by Center for Bioinformatics, Northwest University.
- 16.Sun QH, Cao HJ, Zhou YY, Wang X, Jiang HQ, Gong LL, Yang Y, Rong R. Biomed Chromatogr. 2016;30:1820–1834. doi: 10.1002/bmc.3758. [DOI] [PubMed] [Google Scholar]
- 17.Zheng L, Fang L, Cong H, Xiang T, Xue M, Yao Z, Wu B, Lin W. Biomed Chromatogr. 2015;29:1750–1758. doi: 10.1002/bmc.3489. [DOI] [PubMed] [Google Scholar]
- 18.Cheng XY, Zhang X, Liao M, Liang CJ, Diao XP, Zhang LT. Chin Tradit Herbal Drugs. 2017;48:2390–2400. doi: 10.7501/j.issn.0253-2670.2017.12.006. [DOI] [Google Scholar]
- 19.Qiao X, Li R, Song W, Miao WJ, Liu J, Chen HB, Guo DA, Ye M. J Chromatogr A. 2016;1441:83–95. doi: 10.1016/j.chroma.2016.02.079. [DOI] [PubMed] [Google Scholar]
- 20.Xu T, Yang M, Li Y, Chen X, Wang Q, Deng W, Pang X, Yu K, Jiang B, Guan S, Guo DA. Rapid Commun Mass Spectrom. 2013;27:2297–2309. doi: 10.1002/rcm.6696. [DOI] [PubMed] [Google Scholar]
- 21.Zheng YY, Zeng X, Peng W, Wu Z, Su WW. Phytochem Anal. 2018;30:278–291. doi: 10.1002/pca.2812. [DOI] [PubMed] [Google Scholar]
- 22.Zhou J, Cai H, Tu S, Duan Y, Pei K, Xu Y, Liu J, Niu M, Zhang Y, Shen L, Zhou Q. Molecules. 2018;23:3128. doi: 10.3390/molecules23123128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Bai Y, Zheng Y, Pang W, Peng W, Wu H, Yao H, Li P, Deng W, Cheng J, Su W. Molecules. 2018;23:803. doi: 10.3390/molecules23040803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Zhang YY, Wang Q, Qi LW, Qin XY, Qin MJ. J Pharm Biomed Anal. 2011;56:304–314. doi: 10.1016/j.jpba.2011.05.040. [DOI] [PubMed] [Google Scholar]
- 25.Li J, Li WZM, Huang W, Cheung AWH, Bi CWC, Duan R, Guo AJY, Dong TTX, Tsim KWK. J Chromatogr A. 2009;1216:2071–2078. doi: 10.1016/j.chroma.2008.05.082. [DOI] [PubMed] [Google Scholar]
- 26.Zheng GD, Zhou P, Yang H, Li YS, Li P, Liu EH. Food Chem. 2013;136:604–611. doi: 10.1016/j.foodchem.2012.08.040. [DOI] [PubMed] [Google Scholar]
- 27.Cheng M, Ding L, Kan H, Zhang H, Jiang B, Sun Y, Cao S, Li W, Koike K, Qiu F. J Nat Med. 2019;73:847–854. doi: 10.1007/s11418-019-01329-0. [DOI] [PubMed] [Google Scholar]
- 28.Wang CC, Liu YY, Yang HT, Zhang QY, Liao M, Zhang X, Zhang LT. Chin Tradit Herbal Drugs. 2016;47:2534–2539. doi: 10.7501/j.issn.0253-2670.2016.14.024. [DOI] [Google Scholar]
- 29.Xu L, Liu B, Wang F, Gao XH, Wang YQ, Wang HJ, Li N, Zhang JY. China J Chin Materia Med. 2018;43:4534–4540. doi: 10.19540/j.cnki.cjcmm.2018.0120. [DOI] [PubMed] [Google Scholar]
- 30.Sun X, Wen H-M, Cui XB, Lu TL, Li W, Shan CX. Chin Tradit Herbal Drugs. 2016;47:3494–3501. doi: 10.7501/j.issn.0253-2670.2016.19.023. [DOI] [Google Scholar]
- 31.Zhao W, Huang X, Li X, Zhang F, Chen S, Ye M, Huang M, Xu W, Wu S. Molecules. 2015;20:13958–13981. doi: 10.3390/molecules200813958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Li K, Zhang H, Xie H, Liang Y, Wang X, Ito Y. J Liq Chromatogr Relat Technol. 2011;34:1617–1629. doi: 10.1080/10826076.2011.580486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Zhang K, Xu X, Li T, Song YL, Zhao YF, Song QQ, Tu PF. China J Chin Materia Med. 2020;45:899–909. doi: 10.19540/j.cnki.cjcmm.20191106.201. [DOI] [PubMed] [Google Scholar]
- 34.Huang WP, Tan T, Li ZF, OuYang H, Xu X, Zhou B, Feng YL. J Pharm Biomed Anal. 2018;154:236–244. doi: 10.1016/j.jpba.2018.02.020. [DOI] [PubMed] [Google Scholar]
- 35.Shen Y, Feng Z, Yang M, Zhou Z, Han S, Hou J, Li Z, Wu W, Guo DA. J Sep Sci. 2018;41:1888–1895. doi: 10.1002/jssc.201701134. [DOI] [PubMed] [Google Scholar]
- 36.Zheng ZG, Xu YH, Liu F, Zhao TT, Wang RX, Huang PY, Wang RS, Yang AP, Zhu Q. J Pharm Biomed Anal. 2019;169:127–132. doi: 10.1016/j.jpba.2019.03.007. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


